Zhiran Medical, Portfolio Company of Xingze Capital, Showcases Multiple Innovative Brain-Computer Interface Products at Beijing Municipal Party Secretary's Inspection

Recently, Yin Li, Secretary of the Beijing Municipal Committee, conducted a survey on the theme of "Strengthening Basic Research and Key Core Technology Breakthroughs" at Beijing Tiantan Hospital, affiliated with Capital Medical University, among other places. As an innovative representative in China's invasive flexible brain-computer interface field, BCIFlexBCIFlex's Multiple Self-Developed Innovative Products Debut in the Clinical Application Exhibition Area of Brain-Computer Interface Technology. These Include: High-Throughput Invasive Flexible Electrodes, Over 100-Channel Invasive Flexible Brain-Computer Interface Systems, Digital Electroencephalographs, and More.

CEO of BCIFlex, Song QiDuring this research, innovative brain-computer interface achievements with originality and leadership were introduced to the municipal Party Committee leaders.

(Image: Multiple products from BCIFlex debut at the research event)

Source: "Beijing TV"）

Secretary Yin Li pointed out during his research that it is necessary to target the cutting-edge trends in the integrated development of life sciences and information sciences, deepen collaborative innovation involving the government, industry, academia, research, and application, further enhance the organization and management level of hospital research, strengthen cooperation with universities, research institutes, and new R&D institutions, and carry out high-quality scientific research and clinical trials.Stay ahead and strive for breakthroughs in the brain-computer interface field.

As one of the few innovative companies in China that focus on the full-chain R&D of invasive brain-computer interfaces, BCIFlex has internalized "maintaining leadership and striving for breakthroughs" as its development momentum since its establishment in 2022. The company is dedicated to the R&D of a new generation of brain-computer interface platforms based on invasive flexible electrodes.So far, the company has obtained more than 30 technical patents domestically and internationally, covering several core technologies of invasive brain-computer interfaces.

Notably, the BCIFlex team has successfully developed high-throughput invasive flexible electrodes with excellent biocompatibility and ultra-high performance, thanks to decades of R&D accumulation in the field of flexible electrodes. With a thickness of only micrometers, these electrodes enable precise signal acquisition at the neuronal level. Due to their high signal acquisition efficiency and stability, these electrodes give China a significant advantage in the international competition for high-end invasive brain-computer interfaces.

Secretary Yin Li further pointed out in the survey that it is necessary to strengthen original and leading scientific and technological research, actively undertake major national scientific and technological tasks, and promote breakthroughs in key core technologies across the entire chain.

This requirement is highly consistent with BCIFlex's development strategy of "achieving full-chain independent control from R&D to production."Currently, BCIFlex has established R&D laboratories for flexible electrodes, hardware systems, software and decoding algorithms, and implantation robots, and has self-built a clinical-grade micro-nano processing workshop and GMP workshop covering approximately two thousand square meters.Already possesses fully independent and controllable R&D, design, and large-scale production capabilities for clinical-grade brain-computer interface products.

At the same time, BCIFlex has established in-depth strategic cooperation with top clinical institutions such as Tiantan Hospital Affiliated to Capital Medical University, jointly undertaking major national research projects and promoting the clinical transformation of basic research. A preliminary efficient and collaborative innovation ecosystem has been built.